Our patients also showed coordinated release of CCL2 and CXCL8 levels after COVID-19 vaccination, which can be explained by the activation of myeloid cells by the mRNA-loaded lipid nanoparticles of the BNT162b2 vaccine23. This evidence concerns the gene CCL2 and COVID-19.